Purchase Order 75D30120P07349
Award Date
4/28/20
Potential Completion Date
7/14/21
Potential Value
$80K
Federal Agency
CDC Pittsburgh
Awardee
University Of Victoria
Ultimate Awardee
Not listed
NAICS Category
611310 - Colleges, Universities, and Professional Schools
PSC Category
Q301 - Reference Laboratory Testing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Atlanta, GA 30329, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Service Contract Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award (Contract ID 75D30118P00763) was made by the Centers for Disease Control and Prevention (CDC) to the University of Victoria, operating as Advancement Services, for POXVIRUS GENOME SEQUENCING services. The $77,000.00 firm fixed price purchase order does not have a set-aside designation. The University of Victoria is a non-profit educational institution located in Victoria, British Columbia, Canada that has demonstrated expertise in developing specialized scientific...
This is a firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to the University of Victoria, operating as Advancement Services, a non-profit educational institution located in Victoria, British Columbia, Canada. The contract has a ceiling value of $81,250.00 and is for performing poxvirus genome sequences. The University of Victoria has demonstrated expertise in delivering specialized scientific software and services to federal agencies, including...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $241,671.00 firm-fixed-price purchase order to the University of Victoria for ARDI analysis services. The contract does not have a set-aside designation. The University of Victoria, through its Advancement Services division, provides a range of software, research, and professional services to federal agencies including the Centers for Disease Control and Prevention (CDC). Past CDC contracts awarded...
This is a firm fixed price definitive contract awarded by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to Dalhousie University, a research-intensive educational institution, on September 29, 2023. The contract, which is not set-aside, has a potential value of $2,693,797.00 and a performance period ending on March 31, 2026. The contract was awarded under Broad Agency Announcement (BAA) Topic 36 and will involve Dalhousie University providing...
This is a $550,000 firm fixed price contract awarded by the Centers for Disease Control and Prevention (CDC) to the Rector & Visitors of the University of Virginia (UVA), a public research university, for a CPE Risk Study. The contract has an ultimate completion date of September 29, 2017. UVA, which has extensive experience managing complex federally-funded projects, is not performing this contract under a set-aside program. The university frequently serves as both a prime contractor and...
This is a $1,224,290.00 Firm Fixed Price contract awarded by the Centers for Disease Control and Prevention (CDC) to Dalhousie University, a not-for-profit educational institution based in Halifax, Nova Scotia. The contract was awarded under the FY20 Broad Agency Announcement (BAA) Topic 5.1 and has a period of performance through August 31, 2024. The contract does not have a set-aside designation. As a research-intensive university, Dalhousie has a history of executing federal contracts and...
This is a firm fixed-price federal contract award to Vanderbilt University Medical Center (VUMC), a non-profit healthcare provider in Nashville, Tennessee. The contract was awarded by the Centers for Disease Control and Prevention (CDC) on December 18, 2020 for $3,749,778.73 to support COVID-19 host pathogen discovery research under the CDC's Broad Agency Announcement (BAA) program. The contract has a period of performance through November 29, 2022. VUMC, which has a long history of federal...
The U.S. Centers for Disease Control and Prevention (CDC) awarded a $3,600,000.00 definitive, firm-fixed price contract to the University of Wisconsin System (UW System) for the "IDENTIFICATION AND CHARACTERIZATION OF ANTIGENICALLY ADVANCED INFLUENZA VIRUSES". The contract has an ultimate completion date of August 29, 2029 and was awarded on August 30, 2024. There was no set-aside designation for this contract. The University of Wisconsin System, through its University of...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $2.5 million definitive contract to the Scripps Research Institute for genomic sequencing of SARS-CoV-2 to investigate local and cross-border emergence and spread. This contract was awarded under the Centers for Disease Control COVID-19 Broad Agency Announcement, which sought white papers related to developing strategies for protecting communities from COVID-19, including examining the virus's...
This is a federal contract award to the University of Washington (UW) by the Centers for Disease Control and Prevention (CDC) for $742,701.15. The contract, which does not have a set-aside designation, is for FY 2021 BAA TOPIC 8 - WASHINGTON and has an ultimate completion date of February 14, 2022. UW, a leading research university, is delivering viral genome sequencing and open-source software development services to support genetic epidemiology in Washington State through a subcontract with...